Ayala Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$38,013,000 and profit margin reached -5493%. Total operating expenses were $37,593,000.
Profit Margin
| 2018 | 0 | -8.87M | |
|---|---|---|---|
| 2019 | 2.33M | -17.79M | -762.3% |
| 2020 | 3.70M | -30.14M | -813% |
| 2021 | 0 | -38.70M | |
| 2022 | 692K | -38.01M | -5493.21% |
AYLA Income Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 692K | 0 | 3.70M | 2.33M | 0 |
Cost of revenue | 602K | 3.50M | 3.70M | 1.28M | 0 |
Gross profit | 90K | -3.50M | 0 | 1.04M | 0 |
Operating exp. | |||||
Research and development | 27.85M | 29.94M | 22.40M | 14.42M | 5.74M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 37.59M | 39.21M | 29.77M | 18.76M | 9.03M |
Operating income | -37.50M | -41.03M | -29.77M | -17.71M | -9.03M |
Other income (expenses), net | 74K | 1.55M | 56K | 225K | 448K |
Income before tax | -37.42M | -39.47M | -29.72M | -17.48M | -8.58M |
Income tax expense | 584K | -776K | 425K | 306K | 286K |
Net income | -38.01M | -38.70M | -30.14M | -17.79M | -8.87M |
Earnings per share | |||||
Basic EPS | -2.46 | -3.92 | -3.06 | -2.07 | -1.31 |
Diluted EPS | -2.46 | -3.92 | -3.06 | -2.07 | -1.31 |
| Data source | Data source | Data source |